PETHEMA ALL-93研究结果:成人高危急性淋巴细胞白血病缓解后维持治疗、异基因和自体造血干细胞移植的疗效比较

    Comparison of Intensive Chemotherapy, Allogeneic or Autologous Stem Cell Transplantation as Post-Remission Treatment for Adult Patients with High-Risk Acute Lymphoblastic Leukemia. Results of the PETHEMA ALL-93 Trial

    /

    返回文章
    返回